| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/05/2006 | WO2006105194A2 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
| 10/05/2006 | WO2006105063A1 Heterobicylic inhibitors of tgfbeta |
| 10/05/2006 | WO2006104945A2 Hepatitis c therapies |
| 10/05/2006 | WO2006104403A1 Skin treatment compositions |
| 10/05/2006 | WO2006104401A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104400A1 Copper antagonist compositions |
| 10/05/2006 | WO2006104396A1 Pre-complexed copper antagonist compositions |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006103999A1 Novel carbapenem compound |
| 10/05/2006 | WO2006103527A1 Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs |
| 10/05/2006 | WO2006103429A2 High affinity hiv t cell receptors |
| 10/05/2006 | WO2006103399A1 Hiv integrase inhibitors |
| 10/05/2006 | WO2006103255A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | WO2006103010A1 Cyclic iminopeptide derivatives |
| 10/05/2006 | WO2006103009A1 Antibacterial amide macrocycles vi |
| 10/05/2006 | WO2006102766A1 Garlic extract and chitosan compositions, and uses thereof |
| 10/05/2006 | WO2006085932A3 Anti-viral uses of borinic acid complexes |
| 10/05/2006 | WO2006059247A3 VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
| 10/05/2006 | WO2006020276A3 Antiviral compounds |
| 10/05/2006 | WO2005042028A3 Il-13 conjugated to an immunogen and uses thereof |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223983 Lipopeptide stereoisomers, methods for preparing same and useful intermediates |
| 10/05/2006 | US20060223847 Anti-coronavirus drug |
| 10/05/2006 | US20060223823 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223819 Quinoline Derivatives as NK-3 Antagonists |
| 10/05/2006 | US20060223801 Pyrrol derivatives with antibacterial activity |
| 10/05/2006 | US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics |
| 10/05/2006 | US20060223789 Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223755 biodrug having affinity to bacterial and fungal toxins, and especially to lipopolysaccharide or lipoteichoic acid; treating a fungal or bacterial infection; ear infection, upper respiratory infection, sinusitis, otitis |
| 10/05/2006 | US20060223752 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060223180 Methods to mobilize progenitor/stem cells |
| 10/05/2006 | US20060223156 Controlled dissolution crosslinked protein in crystals |
| 10/05/2006 | US20060223082 Map |
| 10/05/2006 | US20060222723 Terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
| 10/05/2006 | US20060222665 Virus vaccine |
| 10/05/2006 | US20060222661 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 10/05/2006 | US20060222652 Molecular antigen array |
| 10/05/2006 | US20060222629 Compositions and methods for delivery of genetic material |
| 10/05/2006 | US20060222628 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses |
| 10/05/2006 | DE112004002032T5 Concentricolid und seine Derivate, Verfahren zum Herstellen pharmazeutischer Zusammensetzungen umfassend deren Verwendung Concentricolid and its derivatives, method for preparing pharmaceutical compositions comprising the use of |
| 10/05/2006 | DE102005014248A1 Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid A pharmaceutical preparation of N- [5- (aminosulfonyl) -4-methyl-1,3-thiazol-2-yl] -N-methyl-2- [4- (2-pyridinyl) phenyl] acetamide |
| 10/05/2006 | CA2604352A1 Garlic extract and chitosan compositions, and uses thereof |
| 10/05/2006 | CA2602777A1 Gitr binding molecules and uses therefor |
| 10/05/2006 | CA2602743A1 Antibacterial amide macrocycles vi |
| 10/05/2006 | CA2602691A1 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application |
| 10/05/2006 | CA2602641A1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment |
| 10/05/2006 | CA2602533A1 Use of c-nucleoside analogs for treatment of hepatitis c related viral infections |
| 10/05/2006 | CA2602463A1 High affinity hiv t cell receptors |
| 10/05/2006 | CA2602284A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | CA2602108A1 Skin treatment compositions |
| 10/05/2006 | CA2600374A1 Novel carbapenem compound |
| 10/04/2006 | EP1707633A1 Alphavirus vectors for paramyxovirus vaccines |
| 10/04/2006 | EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/04/2006 | EP1707566A1 Deazapurines and uses thereof |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1707210A1 Antiviral preparation |
| 10/04/2006 | EP1707206A1 Piperazine derivates for the inhibition of beta-secretase, cathepsin D, plasmepsin ll and HIV protease and for the treatment of malaria, Alzeheimer and AIDS |
| 10/04/2006 | EP1707202A1 Organic compounds |
| 10/04/2006 | EP1707193A2 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases |
| 10/04/2006 | EP1706114A1 Chemical inhibitors of soluble adenylyl cyclase (sac) |
| 10/04/2006 | EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide |
| 10/04/2006 | EP1482936B1 Ophthalmic composition comprising ascomycin |
| 10/04/2006 | EP1451194B1 Preparation of levofloxacin hemihydrate |
| 10/04/2006 | EP1420799B1 Use of atazanavir in hiv therapy |
| 10/04/2006 | EP1395266B1 Use of antiviral nucleoside derivatives for the manufacture of a medicament for the treatment of hepatitis c infections |
| 10/04/2006 | EP1392695B1 Triazolopyrimidines |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | EP1232171B1 Method of preparing clarithromycin |
| 10/04/2006 | EP1171175B1 Active agent coated endoprosthesis with long-term stability |
| 10/04/2006 | EP1082435B1 Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 10/04/2006 | EP0957936B1 Formulations of recombinant papillomavirus vaccines |
| 10/04/2006 | EP0783525B1 Humanized antibodies against respiratory syncytial virus |
| 10/04/2006 | CN1842588A Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 10/04/2006 | CN1842531A Crystal of 1-methyl carbapenem compound |
| 10/04/2006 | CN1842522A Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 10/04/2006 | CN1842345A Oral solid dose vaccine |
| 10/04/2006 | CN1842343A Use of modified cyclosporins for the treatment of hcv disorders |
| 10/04/2006 | CN1842341A Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng |
| 10/04/2006 | CN1842339A Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
| 10/04/2006 | CN1840684A Process for fermentation preparation of nosiheptide by using streptomycete |
| 10/04/2006 | CN1840665A Virulence genes, proteins, and their use |
| 10/04/2006 | CN1840659A Method of treating endotoxemia |
| 10/04/2006 | CN1840544A ESC42 protein, preparation method and use thereof |
| 10/04/2006 | CN1840538A 1-(2'-deoxy-2'-fluoro-3'-O-amino acid ester-beta-L-furyl arabinosyl)-5-methyl uracil and its application |
| 10/04/2006 | CN1840204A Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 10/04/2006 | CN1840203A Oligonucleotide drug for preventing and treating influenza virus infection |
| 10/04/2006 | CN1840188A A recombined smallpox vaccine - SARS vaccine and preparation method thereof |
| 10/04/2006 | CN1840184A Lysozyme liposome and preparation method thereof |
| 10/04/2006 | CN1840182A Application of N-acetylmuramide glycanohydrla in treatment of AIDS |
| 10/04/2006 | CN1840180A Application of bovine lactoferricin in preparation of medicine for treating gastric disease and reducing secretion of gastric acid |
| 10/04/2006 | CN1840179A Application of bovine lactoferricin in preparation of medicine for treating HP infected gastric disease |
| 10/04/2006 | CN1840177A Injection liquid of thymic peptide alpha 1 and preparation method thereof |
| 10/04/2006 | CN1840174A Application of polygonatum cyrtonema Hua. Lectin II protein in medicine preparation for treating or preventing AIDS |
| 10/04/2006 | CN1840163A Cold-treating influenza-preventing medicine |
| 10/04/2006 | CN1840156A Effervescence tablet for treating female genital disease and preparation method thereof |